- Sarcoma of the breast: outcome and reconstructive options.
Toesca A, Spitaleri G, De Pas T, Botteri E, Gentilini O, Bottiglieri L, Rotmentsz N, Sangalli C, Marrazzo E, Cassano E, Veronesi P, Rietjens M, Luini A.
Clin Breast Cancer. 2012 Dec;12(6):438-44. doi: 10.1016/j.clbc.2012.09.008. Epub 2012 Oct 11.
PMID: 23062708 - Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates.
Gentilini O, Botteri E, Veronesi P, Sangalli C, Del Castillo A, Ballardini B, Galimberti V, Rietjens M, Colleoni M, Luini A, Veronesi U.
Ann Surg Oncol. 2012 Nov;19(12):3771-6. doi: 10.1245/s10434-012-2404-5. Epub 2012 May 23.
PMID: 22618719 - Do early breast cancer patients with only sentinel lymph node biopsy experience lower psychological morbidity over time?
Didier F, Radice D, Maldifassi A, Gatti G, Luini A, Leonardi C, Lupo F, Rotmensz N, Santillo B, Galimberti V, Goldhirsch A.
Breast J. 2012 Nov-Dec;18(6):622-4. doi: 10.1111/tbj.12024. Epub 2012 Oct 11. No abstract available.
PMID: 23057838 - Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4).
Orecchia R, Jereczek-Fossa BA, Rondi E, Bossi-Zanetti I, Meaglia I, Luraschi R, Leonardi MC, Rotmensz N, Botteri E, Fodor C, Cecconi A, Morra A, Lazzari R, Ferrari A, Cattani F, Galimberti V,Luini A, Veronesi P, Zurrida S, Magrini S, Doerr W, Humble N, Trott KR, Ottolenghi A, Smyth V, Veronesi U.
Tumori. 2012 Nov;98(6):715-21. doi: 10.1700/1217.13494. Erratum in: Tumori. 2013 May-Jun;99(3):e140.
PMID: 23389357 - Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Trentin C, Dominelli V, Maisonneuve P, Menna S, Bazolli B, Luini A, Cassano E.
Breast. 2012 Oct;21(5):635-40. doi: 10.1016/j.breast.2012.06.009. Epub 2012 Jul 12.
PMID: 22795363 - Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.
Garcia-Etienne CA, Tomatis M, Heil J, Friedrichs K, Kreienberg R, Denk A, Kiechle M, Lorenz-Salehi F, Kimmig R, Emons G, Danaei M, Heyl V, Heindrichs U, Rageth CJ, Janni W, Marotti L, del Turco MR, Ponti A; eusomaDB Working Group.
Eur J Cancer. 2012 Sep;48(13):1947-56. doi: 10.1016/j.ejca.2012.03.008. Epub 2012 Apr 4.
PMID: 22483323 - Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
Bonanni B, Puntoni M, Cazzaniga M, Pruneri G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS, Galimberti V, Veronesi P, Johansson H, Aristarco V, Bassi F, Luini A, Lazzeroni M, Varricchio C, Viale G, Bruzzi P, Decensi A.
J Clin Oncol. 2012 Jul 20;30(21):2593-600. doi: 10.1200/JCO.2011.39.3769. Epub 2012 May 7.
PMID: 22564993 - Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breastcancer.
Munzone E, Botteri E, Sciandivasci A, Curigliano G, Nolè F, Mastropasqua M, Rotmensz N, Colleoni M, Esposito A, Adamoli L, Luini A, Goldhirsch A, Viale G.
Breast Cancer Res Treat. 2012 Jul;134(1):277-82. doi: 10.1007/s10549-012-2040-6. Epub 2012 Apr 1.
PMID: 22467243 - How do the ASTRO consensus statement guidelines for the application of accelerated partial breastirradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.
Leonardi MC, Maisonneuve P, Mastropasqua MG, Morra A, Lazzari R, Rotmensz N, Sangalli C, Luini A, Veronesi U, Orecchia R.
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):806-13. doi: 10.1016/j.ijrobp.2011.08.014. Epub 2012 Jan 13.
PMID: 22245196 - Outcome of special types of luminal breast cancer.
Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, Intra M, Montagna E, Cancello G, Cardillo A, Mazza M, Perri G, Iorfida M, Pruneri G, Goldhirsch A, Viale G.
Ann Oncol. 2012 Jun;23(6):1428-36. doi: 10.1093/annonc/mdr461. Epub 2011 Oct 29.
PMID: 22039080 - Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab.
Dellapasqua S, Bagnardi V, Bertolini F, Sandri MT, Pastrello D, Cancello G, Montagna E, Balduzzi A, Mancuso P, Luini A, Goldhirsch A, Colleoni M.
Breast. 2012 Jun;21(3):309-13. doi: 10.1016/j.breast.2012.01.015. Epub 2012 Feb 16.
PMID: 22341133 - Invasive lobular breast cancer: subtypes and outcome.
Iorfida M, Maiorano E, Orvieto E, Maisonneuve P, Bottiglieri L, Rotmensz N, Montagna E, Dellapasqua S, Veronesi P, Galimberti V, Luini A, Goldhirsch A, Colleoni M, Viale G.
Breast Cancer Res Treat. 2012 Jun;133(2):713-23. doi: 10.1007/s10549-012-2002-z. Epub 2012 Mar 8.
PMID: 22399188 - Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.
Montagna E, Cancello G, Bagnardi V, Pastrello D, Dellapasqua S, Perri G, Viale G, Veronesi P, Luini A, Intra M, Calleri A, Rampinelli C, Goldhirsch A, Bertolini F, Colleoni M.
Clin Breast Cancer. 2012 Jun;12(3):207-14. doi: 10.1016/j.clbc.2012.03.008. Epub 2012 Apr 20.
PMID: 22520733 - Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stagebreast cancer.
Ribi K, Aldridge J, Phillips KA, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J; BIG 1-98 Collaborative Group; InternationalBreast Cancer Study Group.
Br J Cancer. 2012 May 8;106(10):1618-25. doi: 10.1038/bjc.2012.156. Epub 2012 Apr 24.
PMID: 22531635 - Long-term side effects and cosmetic outcome in a pool of breast cancer patients treated with intraoperative radiotherapy with electrons as sole treatment.
Leonardi MC, Ivaldi GB, Santoro L, Lazzari R, Ferrari A, Morra A, Caldarella P, Burgoa L, Bassi FD, Sangalli C, Rotmensz N, Luini A, Veronesi U, Orecchia R.
Tumori. 2012 May-Jun;98(3):324-30. doi: 10.1700/1125.12400.
PMID: 22825508 - Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible?
Didier F, Arnaboldi P, Gandini S, Maldifassi A, Goldhirsch A, Radice D, Minotti I, Ballardini B, Luini A, Santillo B, Rietjens M, Petit JY.
Breast Cancer Res Treat. 2012 Apr;132(3):1177-84. doi: 10.1007/s10549-012-1983-y. Epub 2012 Feb 19.
PMID: 22350788 - Primary and secondary angiosarcomas of the breast: a single institution experience.
Fraga-Guedes C, Gobbi H, Mastropasqua MG, Botteri E, Luini A, Viale G.
Breast Cancer Res Treat. 2012 Apr;132(3):1081-8. doi: 10.1007/s10549-011-1931-2. Epub 2011 Dec 30.
PMID: 22207278 - Breast cancer subtypes and outcome after local and regional relapse.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Renne G, Cancello G, Balduzzi A, Scarano E, Veronesi P, Luini A, Zurrida S, Monti S, Mastropasqua MG, Bottiglieri L, Goldhirsch A, Colleoni M.
Ann Oncol. 2012 Feb;23(2):324-31. doi: 10.1093/annonc/mdr129. Epub 2011 Apr 27.
PMID: 21525402 - Prognostic role of CA15.3 in 7942 patients with operable breast cancer.
Sandri MT, Salvatici M, Botteri E, Passerini R, Zorzino L, Rotmensz N, Luini A, Mauro C, Bagnardi V, Cassatella MC, Bottari F, Casadio C, Colleoni M.
Breast Cancer Res Treat. 2012 Feb;132(1):317-26. doi: 10.1007/s10549-011-1863-x. Epub 2011 Nov 9.
PMID: 22065291 - Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
Galimberti V, Botteri E, Chifu C, Gentilini O, Luini A, Intra M, Baratella P, Sargenti M, Zurrida S, Veronesi P, Rotmensz N, Viale G, Sonzogni A, Colleoni M, Veronesi U.
Breast Cancer Res Treat. 2012 Feb;131(3):819-25. doi: 10.1007/s10549-011-1486-2. Epub 2011 Apr 6.
PMID: 21468637 - The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Chirgwin J, Sun Z, Smith I, Price KN, Thürlimann B, Ejlertsen B, Bonnefoi H, Regan MM, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups.
Breast Cancer Res Treat. 2012 Jan;131(1):295-306. doi: 10.1007/s10549-011-1741-6. Epub 2011 Sep 4.
PMID: 21892704 - Breast cancer: from “maximum tolerable” to “minimum effective” treatment.
Veronesi U, Stafyla V, Luini A, Veronesi P.
Front Oncol. 2012 Oct 8;2:125. doi: 10.3389/fonc.2012.00125. eCollection 2012.
PMID: 23061042 - Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG).
Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20.
PMID: 22018631 - Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
Gentilini O, Veronesi P, Botteri E, Soggiu F, Trifirò G, Lissidini G, Galimberti V, Musmeci S, Raviele PR, Toesca A, Ratini S, Del Castillo A, Colleoni M, Talakhadze N, Rotmensz N, Viale G, Veronesi U,Luini A.
Ann Surg Oncol. 2011 Oct;18(10):2879-84. doi: 10.1245/s10434-011-1694-3. Epub 2011 Apr 9. Erratum in: Ann Surg Oncol. 2011 Dec; 18 Suppl 3:S322. Castillo, Andres Del [corrected to Del Castillo, Andres].
PMID: 21479691 - Local therapy for breast cancer in malignant lymphoma survivors.
Intra M, Mattar D, Sangalli C, Rotmensz N, Viale G, Galimberti V, Luini A, Veronesi P, Colleoni M, Zurrida S, Orecchia R, Veronesi U.
Breast. 2011 Oct;20 Suppl 3:S99-103. doi: 10.1016/S0960-9776(11)70304-6.
PMID: 22015303 - Positive axillary sentinel lymph node: is axillary dissection always necessary?
Galimberti V, Chifu C, Rodriguez Perez S, Veronesi P, Intra M, Botteri E, Mastropasqua M, Colleoni M, Luini A, Veronesi U.
Breast. 2011 Oct;20 Suppl 3:S96-8. doi: 10.1016/S0960-9776(11)70303-4. Review.
PMID: 22015302 - Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, Cardillo A, Ghisini R, Galimberti V, Veronesi P, Monti S, Luini A, Raviele PR, Mastropasqua MG, Goldhirsch A, Colleoni M.
Breast Cancer Res Treat. 2011 Oct;129(3):867-75. doi: 10.1007/s10549-011-1697-6. Epub 2011 Aug 6.
PMID: 21822638 - Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer.
Dellapasqua S, Mazza M, Rosa D, Ghisini R, Scarano E, Torrisi R, Maisonneuve P, Viale G, Cassano E, Veronesi P, Luini A, Goldhirsch A, Colleoni M.
Breast. 2011 Aug;20(4):319-23. doi: 10.1016/j.breast.2011.02.014. Epub 2011 Mar 11.
PMID: 21397505 - Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial.
Decensi A, Puntoni M, Pruneri G, Guerrieri-Gonzaga A, Lazzeroni M, Serrano D, Macis D, Johansson H, Pala O, Luini A, Veronesi P, Galimberti V, Dotti MC, Viale G, Bonanni B.
Cancer Prev Res (Phila). 2011 Aug;4(8):1181-9. doi: 10.1158/1940-6207.CAPR-10-0337. Epub 2011 Jun 17.
PMID: 21685235 - The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy.
Farante G, Zurrida S, Galimberti V, Veronesi P, Curigliano G, Luini A, Goldhirsch A, Veronesi U.
Breast Cancer Res Treat. 2011 Jul;128(2):369-78. doi: 10.1007/s10549-010-1124-4. Epub 2010 Aug 26. Erratum in:Breast Cancer Res Treat. 2011 Jul;128(2):379. Dosage error in article text.
PMID: 20740312 - Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.
Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Montagna E, Dellapasqua S, Iorfida M, Cardillo A, Veronesi P, Luini A, Intra M, Gentilini O, Scarano E, Goldhirsch A, Colleoni M.
Breast Cancer Res Treat. 2011 Jun;127(3):713-20. doi: 10.1007/s10549-011-1465-7. Epub 2011 Mar 31.
PMID: 21452022 - Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.
Regan MM, Price KN, Giobbie-Hurder A, Thürlimann B, Gelber RD; International Breast Cancer Study Group and BIG 1-98 Collaborative Group.
Breast Cancer Res. 2011 May 26;13(3):209. doi: 10.1186/bcr2837. Review.
PMID: 21635709 - Risk factors for relapse after conservative treatment in T1-T2 breast cancer with one to three positive axillary nodes: results of an observational study.
Aristei C, Leonardi C, Stracci F, Palumbo I, Luini A, Viale G, Cristallini EG, Cavaliere A, Orecchia R.
Ann Oncol. 2011 Apr;22(4):842-7. doi: 10.1093/annonc/mdq470. Epub 2010 Nov 3.
PMID: 21048040 - Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.
Torrisi R, Bagnardi V, Rotmensz N, Scarano E, Iorfida M, Veronesi P, Luini A, Viale G, Santoro A, Colleoni M, Goldhirsch A.
Breast Cancer Res Treat. 2011 Apr;126(2):431-41. doi: 10.1007/s10549-010-1340-y. Epub 2011 Jan 8.
PMID: 21221766 - Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology.
Galimberti V, Maisonneuve P, Rotmensz N, Viale G, Sangalli C, Sargenti M, Brenelli F, Gentilini O, Intra M, Bassi F, Luini A, Zurrida S, Veronesi P, Colleoni M, Veronesi U.
Ann Surg. 2011 Mar;253(3):580-4. doi: 10.1097/SLA.0b013e31820d9a81.
PMID: 21248632 - Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer.
Torrisi R, Montagna E, Scarano E, Dellapasqua S, Cancello G, Iorfida M, Luini A, Veronesi P, Viale G, Goldhirsch A, Colleoni M.
Breast. 2011 Feb;20(1):34-8. doi: 10.1016/j.breast.2010.06.005. Epub 2010 Jul 16.
PMID: 20638282 - Sentinel Lymph Node Biopsy in Early Breast Cancer: The Experience of the European Institute of Oncology in Special Clinical Scenarios.
Toesca A, Luini A, Veronesi P, Intra M, Gentilini O.
Breast Care (Basel). 2011;6(3):208-214. Epub 2011 Jun 3.
PMID: 21779226